Published :
Tables : 46
Figures : 43
Category : Healthcare
No. of Pages : 216
Report Code : HC-1298
Veterinary Vaccines Market is poised to register a CAGR of 7.2% during the forecast period 2022 to 2028. Veterinary vaccinations are parenteral medications used to halt infectious illnesses brought on by various causative Agents. These vaccinations protect animals against numerous illnesses that can be fatal. The longevity, health, and overall production of livestock and pets can all be effectively increased with the help of veterinary vaccines. Live-attenuated, inactivated, recombinant, toxoid, and other types of vaccines are included in the classification of veterinary vaccines. Vaccinating companion animals, poultry, swine, ruminants, and aquaculture is a major usage for these products. The most widely used veterinary vaccinations include those for rabies, equine influenza virus, and foot-and-mouth disease. These vaccines prevent the spread of infectious diseases by simulating naturally developed immunity. The Veterinary Vaccines Market is expected to expand steadily due to rising pet ownership in developed countries and an increase in the number of livestock and poultry in emerging nations. The Veterinary Vaccines Market is expected to rise as a result of the surge in vaccine R&D funding, which prevents the development of antibiotic-resistant pathogens. A number of new vaccinations have also been developed as a result of the rising need for animal vaccines. Additionally, the spread of zoonotic and animal illnesses as well as the ongoing development of technologically improved vaccines have changed the dynamics of the market. The market has seen a shift in trend from live attenuated vaccines to DNA vaccines, and recombinant vaccination solutions are being quickly adopted. These elements are expected to favourably fuel the global market for veterinary vaccines. The growth of the market will be restricted by a number of limitations and obstacles. This market is one of the lucrative alternatives of investments seeking attention and investments from both non-government and government key players. The shifting emphasis on healthy animal husbandry and an increasing number of pet owners are other important factors boosting the market proliferation. The intervention of the government in channel distribution whereas, it is affecting the overall profits incurred by the manufacturers of the veterinary vaccines. Attenuated vaccines segment dominated the market owing to advantages, for instance, enhanced long-term prevention and improved effectivity. Cattle vaccinations held the largest global veterinary vaccines market share owing to the rise in the insistence for safe and effective animal products. The companion animal vaccines are currently proliferating due to an increase in the number of pet ownerships across the world. The North American region subjugated the market in 2018. Rising animal product commercialization and increasing awareness regarding the health of animals are prime reasons for the region’s domination over the forecast period. The Asia Pacific region is predicted to exhibit rapid augmentation during the forecast timeframe due to faster adoption of animal vaccines for better animal health and high-quality food products. Key market players included in the global veterinary vaccines industry are Zoetis, Merck Animal Health, Boehringer Ingelheim, Elanco, Ceva, Virbac,Vetoquinol, Phibro Animal Health, Hester Biosciences, HIPRA, Biogenesis Bago, Tianjin Ringpu, China Animal Husbandry, Jinyu Bio-technology, Endovac Animal Health, Brilliant Bio Pharma Private Limited, Aptimmune Biologics, Indian Immunologicals Ltd., Torigen, VEROVACCiNES. Global Veterinary Vaccines Market Segmentation: By Type • Porcine Vaccines • Poultry Vaccines • Livestock Vaccines o Bovine Vaccines o Small Ruminant Vaccines • Companion Animal Vaccines o Canine Vaccines o Feline Vaccines • Aquaculture Vaccines • Other Animal Vaccines By Disease • Porcine • Poultry • Livestock o Bovine o Small Ruminants • Companion Animals o Canine o Feline • Aquaculture By Technology Live Attenuated Vaccines Inactivated Vaccines Toxoid Vaccines Recombinant Vaccines Other Vaccines By Region Europe North America Asia Pacific Latin America Middle East and Africa Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Key Takeaways: Growth prospects SWOT analysis Key trends Key data-points affecting market growth Objectives of the Study: To provide with an exhaustive analysis on the global veterinary vaccines market by type, by disease, by technology and by region To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions Profiling of companies to evaluate their market shares, strategies, financials and core competencies Flexible Delivery Model: We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement The customization Mobility Care offered are free of charge with purchase of any license of the report You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Veterinary vaccinations are parenteral medications used to halt infectious illnesses brought on by various causative Agents. These vaccinations protect animals against numerous illnesses that can be fatal. The longevity, health, and overall production of livestock and pets can all be effectively increased with the help of veterinary vaccines. Live-attenuated, inactivated, recombinant, toxoid, and other types of vaccines are included in the classification of veterinary vaccines. Vaccinating companion animals, poultry, swine, ruminants, and aquaculture is a major usage for these products. The most widely used veterinary vaccinations include those for rabies, equine influenza virus, and foot-and-mouth disease. These vaccines prevent the spread of infectious diseases by simulating naturally developed immunity. The Veterinary Vaccines Market is expected to expand steadily due to rising pet ownership in developed countries and an increase in the number of livestock and poultry in emerging nations. The Veterinary Vaccines Market is expected to rise as a result of the surge in vaccine R&D funding, which prevents the development of antibiotic-resistant pathogens. A number of new vaccinations have also been developed as a result of the rising need for animal vaccines. Additionally, the spread of zoonotic and animal illnesses as well as the ongoing development of technologically improved vaccines have changed the dynamics of the market. The market has seen a shift in trend from live attenuated vaccines to DNA vaccines, and recombinant vaccination solutions are being quickly adopted. These elements are expected to favourably fuel the global market for veterinary vaccines. The growth of the market will be restricted by a number of limitations and obstacles.
This market is one of the lucrative alternatives of investments seeking attention and investments from both non-government and government key players. The shifting emphasis on healthy animal husbandry and an increasing number of pet owners are other important factors boosting the market proliferation. The intervention of the government in channel distribution whereas, it is affecting the overall profits incurred by the manufacturers of the veterinary vaccines.
Attenuated vaccines segment dominated the market owing to advantages, for instance, enhanced long-term prevention and improved effectivity. Cattle vaccinations held the largest global veterinary vaccines market share owing to the rise in the insistence for safe and effective animal products. The companion animal vaccines are currently proliferating due to an increase in the number of pet ownerships across the world. The North American region subjugated the market in 2018. Rising animal product commercialization and increasing awareness regarding the health of animals are prime reasons for the region’s domination over the forecast period. The Asia Pacific region is predicted to exhibit rapid augmentation during the forecast timeframe due to faster adoption of animal vaccines for better animal health and high-quality food products.
Key market players included in the global veterinary vaccines industry are Zoetis, Merck Animal Health, Boehringer Ingelheim, Elanco, Ceva, Virbac,Vetoquinol, Phibro Animal Health, Hester Biosciences, HIPRA, Biogenesis Bago, Tianjin Ringpu, China Animal Husbandry, Jinyu Bio-technology, Endovac Animal Health, Brilliant Bio Pharma Private Limited, Aptimmune Biologics, Indian Immunologicals Ltd., Torigen, VEROVACCiNES.
Global Veterinary Vaccines Market Segmentation:
By Type
• Porcine Vaccines • Poultry Vaccines • Livestock Vaccines o Bovine Vaccines o Small Ruminant Vaccines • Companion Animal Vaccines o Canine Vaccines o Feline Vaccines • Aquaculture Vaccines • Other Animal Vaccines
By Disease
• Porcine • Poultry • Livestock o Bovine o Small Ruminants • Companion Animals o Canine o Feline • Aquaculture
By Technology
By Region
Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants
FutureWise Key Takeaways:
Objectives of the Study:
Flexible Delivery Model:
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Veterinary Vaccines Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Veterinary Vaccines Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Veterinary Vaccines Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Veterinary Vaccines Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Veterinary Vaccines Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Porcine Vaccines 7.2. Poultry Vaccine 7.3. Livestock Vaccine 7.3.1. Bovine Vaccines 7.3.2. Small Ruminant Vaccines 7.4. Companion Animal Vaccine 7.4.1. Canine Vaccine 7.4.2. Feline Vaccine 7.5. Aquaculture Vaccines 7.6. Other Animal Vaccines 8. Veterinary Vaccines Market, By Disease Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Porcine 8.2. Poultry 8.3. Livestock 8.3.1. Bovine 8.3.2. Small Ruminant 8.4. Companion Animal 8.4.1. Canine 8.4.2. Feline 8.5. Aquaculture 9. Veterinary Vaccines Market, By Technology Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Live Attenuated Vaccines 9.2. Inactivated Vaccines 9.3. Toxoid Vaccines 9.4. Recombinant Vaccines 9.5. Other Vaccines 10. North America Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2022-2028 11. Latin America Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 11.1. Introduction 11.2. Regional Market Trends 11.3. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.3.1. Brazil 11.3.2. Venezuela 11.3.3. Argentina 11.3.4. Rest of Latin America 11.4. Market Size (USD Million) Forecast for Latin America 2022-2028 12. Europe Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Switzerland 12.2.9. Rest of Western Europe 12.3. Market Size (USD Million) Forecast for Europe 2022-2028 13. Asia Pacific Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Japan 13.2.2. China 13.2.3. Singapore 13.2.4. India 13.2.5. Australia and New Zealand 13.2.6. ASEAN 13.2.7. South Korea 13.2.8. Taiwan 13.2.9. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 14. Middle East and Africa Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. GCC 14.2.2. Israel 14.2.3. South Africa 14.2.4. Rest of MEA 14.3. Market Size (USD Million) Forecast for MEA 2022-2028 15. Market Share Analysis and Competitive Landscape 15.1. Global Landscape - Key Players, Revenue and Presence 15.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 15.3. Global Emerging Companies 15.4. North America - Market Share Analysis and Key Regional Players 15.5. Europe - Market Share Analysis and Key Regional Players 15.6. Asia Pacific - Market Share Analysis and Key Regional Players 15.7. Global Key Player - Growth Matrix 16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts) 16.1. Zoetis 16.1.1. Company Overview 16.1.2. Product Portfolio 16.1.3. SWOT Analysis 16.1.4. Financial Overview 16.1.5. Strategic Overview 16.2. Merck Animal Health 16.2.1. Company Overview 16.2.2. Product Portfolio 16.2.3. SWOT Analysis 16.2.4. Financial Overview 16.2.5. Strategic Overview 16.3. Boehringer Ingelheim 16.3.1. Company Overview 16.3.2. Product Portfolio 16.3.3. SWOT Analysis 16.3.4. Financial Overview 16.3.5. Strategic Overview 16.4. Elanco 16.4.1. Company Overview 16.4.2. Product Portfolio 16.4.3. SWOT Analysis 16.4.4. Financial Overview 16.4.5. Strategic Overview 16.5 Ceva 16.5.1. Company Overview 16.5.2. Product Portfolio 16.5.3. SWOT Analysis 16.5.4. Financial Overview 16.5.5. Strategic Overview 16.6 Virbac 16.6.1. Company Overview 16.6.2. Product Portfolio 16.6.3. SWOT Analysis 16.6.4. Financial Overview 16.6.5. Strategic Overview 16.7. Vetoqunol 16.7.1. Company Overview 16.7.2. Product Portfolio 16.7.3. SWOT Analysis 16.7.4. Financial Overview 16.7.5. Strategic Overview 16.8. Phibro Animal Health 16.8.1. Company Overview 16.8.2. Product Portfolio 16.8.3. SWOT Analysis 16.8.4. Financial Overview 16.8.5. Strategic Overview 16.9. Hester Biosciences 16.9.1. Company Overview 16.9.2. Product Portfolio 16.9.3. SWOT Analysis 16.9.4. Financial Overview 16.9.5. Strategic Overview 16.10. Hipra 16.10.1. Company Overview 16.10.2. Product Portfolio 16.10.3. SWOT Analysis 16.10.4. Financial Overview 16.10.5. Strategic Overview 16.11. Endovac Animal Health 16.11.1. Company Overview 16.11.2. Product Portfolio 16.11.3. SWOT Analysis 16.11.4. Financial Overview 16.11.5. Strategic Overview 16.12. Biogenesis Bago 16.12.1. Company Overview 16.12.2. Product Portfolio 16.12.3. SWOT Analysis 16.12.4. Financial Overview 16.12.5. Strategic Overview 16.13. Tianjin Ringpu 16.13.1. Company Overview 16.13.2. Product Portfolio 16.13.3. SWOT Analysis 16.13.4. Financial Overview 16.13.5. Strategic Overview 16.14. China Animal Husbandry. 16.14.1. Company Overview 16.14.2. Product Portfolio 16.14.3. SWOT Analysis 16.14.4. Financial Overview 16.14.5. Strategic Overview 16.16. Jinyu Bio-Technology 16.16.1. Company Overview 16.16.2. Product Portfolio 16.16.3. SWOT Analysis 16.16.4. Financial Overview 16.16.5. Strategic Overview 16.16. Brilliant Bio Pharma Private Limited 16.16.1. Company Overview 16.16.2. Product Portfolio 16.16.3. SWOT Analysis 16.16.4. Financial Overview 16.16.5. Strategic Overview 16.17. Aptimmune Biologics 16.17.1. Company Overview 16.17.2. Product Portfolio 16.17.3. SWOT Analysis 16.17.4. Financial Overview 16.17.5. Strategic Overview 16.17. Indian Immunologicals Ltd. 16.17.1. Company Overview 16.17.2. Product Portfolio 16.17.3. SWOT Analysis 16.17.4. Financial Overview 16.17.5. Strategic Overview 16.19. Torigen 16.19.1. Company Overview 16.19.2. Product Portfolio 16.19.3. SWOT Analysis 16.19.4. Financial Overview 16.19.5. Strategic Overview 16.20. VEROVACCiNES 16.20.1. Company Overview 16.20.2. Product Portfolio 16.20.3. SWOT Analysis 16.20.4. Financial Overview 16.20.5. Strategic Overview 17. Pre and Post COVID-19 Impact 17.1. Positive influence on the healthcare industry 17.2. The financial disruption of the manufacturing sector 17.3. Impact of COVID-19 on emerging companies 17.4. Significant mandates in the healthcare regulations initiated by administrations 17.5. The overall economic slowdown of the developing and developed nations 18. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics